BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32514656)

  • 21. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
    Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
    Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel mutations and hot-spots in patients with purine nucleoside phosphorylase deficiency.
    Grunebaum E; Zhang J; Roifman CM
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1411-5. PubMed ID: 15571269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Purine nucleoside phosphorylase (PNP) deficiency].
    Sakiyama T
    Nihon Rinsho; 1996 Dec; 54(12):3328-32. PubMed ID: 8976114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stroke in purine nucleoside phosphorylase deficiency.
    Tam DA; Leshner RT
    Pediatr Neurol; 1995 Feb; 12(2):146-8. PubMed ID: 7779212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purine nucleoside phosphorylase (PNP) deficiency: a therapeutic challenge.
    Watson AR; Simmonds HA; Webster DR; Layward L; Evans DI
    Adv Exp Med Biol; 1984; 165 Pt A():53-9. PubMed ID: 6426259
    [No Abstract]   [Full Text] [Related]  

  • 26. TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice.
    Toro A; Grunebaum E
    J Clin Invest; 2006 Oct; 116(10):2717-26. PubMed ID: 16964310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The First Report of a Pregnancy in a Patient with Purine Nucleoside Phosphorylase Deficiency.
    Martin J; Sharma R; Nelson RP; Schubert F; Weida J
    Fetal Pediatr Pathol; 2016; 35(2):120-3. PubMed ID: 26882246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells.
    Ghodke-Puranik Y; Dorschner JM; Vsetecka DM; Amin S; Makol A; Ernste F; Osborn T; Moder K; Chowdhary V; Eliopoulos E; Zervou MI; Goulielmos GN; Jensen MA; Niewold TB
    Arthritis Rheumatol; 2017 Dec; 69(12):2328-2337. PubMed ID: 28859258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Genetic Mutations in the First Swedish Patient with Purine Nucleoside Phosphorylase Deficiency and Clinical Outcome After Hematopoietic Stem Cell Transplantation with HLA-Matched Unrelated Donor.
    Brodszki N; Svensson M; van Kuilenburg AB; Meijer J; Zoetekouw L; Truedsson L; Toporski J
    JIMD Rep; 2015; 24():83-9. PubMed ID: 25967230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic stem cell transplantation in an infant with dedicator of cytokinesis 8 (DOCK8) deficiency associated with systemic lupus erythematosus: A case report.
    Seo E; Lee BH; Lee JH; Park YS; Im HJ; Lee J
    Medicine (Baltimore); 2021 Apr; 100(13):e20866. PubMed ID: 33787566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal uric acid concentrations in a purine nucleoside phosphorylase (PNP) deficient child presenting with severe chicken pox, possible immunodeficiency and developmental delay.
    Hallett RJ; Cronin SM; Morgan G; Duley JA; Fairbanks LD; Simmonds HA
    Adv Exp Med Biol; 1994; 370():387-9. PubMed ID: 7544949
    [No Abstract]   [Full Text] [Related]  

  • 32. Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during expanded newborn screening by liquid chromatography-tandem mass spectrometry.
    la Marca G; Giocaliere E; Malvagia S; Villanelli F; Funghini S; Ombrone D; Della Bona M; Forni G; Canessa C; Ricci S; Romano F; Guerrini R; Resti M; Azzari C
    Clin Chem Lab Med; 2016 Apr; 54(4):627-32. PubMed ID: 26466166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purine nucleoside phosphorylase deficiency in a patient with spastic paraplegia and recurrent infections.
    Ozkinay F; Pehlivan S; Onay H; van den Berg P; Vardar F; Koturoglu G; Aksu G; Unal D; Tekgul H; Can S; Ozkinay C
    J Child Neurol; 2007 Jun; 22(6):741-3. PubMed ID: 17641261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purine nucleoside phosphorylase deficiency (PNP-def) presenting with lymphopenia and developmental delay: successful correction with umbilical cord blood transplantation.
    Myers LA; Hershfield MS; Neale WT; Escolar M; Kurtzberg J
    J Pediatr; 2004 Nov; 145(5):710-2. PubMed ID: 15520787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purine nucleoside phosphorylase deficiency induces p53-mediated intrinsic apoptosis in human induced pluripotent stem cell-derived neurons.
    Tsui M; Biro J; Chan J; Min W; Dobbs K; Notarangelo LD; Grunebaum E
    Sci Rep; 2022 May; 12(1):9084. PubMed ID: 35641516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients.
    Markert ML; Hershfield MS; Schiff RI; Buckley RH
    J Clin Immunol; 1987 Sep; 7(5):389-99. PubMed ID: 3116034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency.
    Aust MR; Andrews LG; Barrett MJ; Norby-Slycord CJ; Markert ML
    Am J Hum Genet; 1992 Oct; 51(4):763-72. PubMed ID: 1384322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in purine nucleoside phosphorylase deficiency.
    Markert ML; Finkel BD; McLaughlin TM; Watson TJ; Collard HR; McMahon CP; Andrews LG; Barrett MJ; Ward FE
    Hum Mutat; 1997; 9(2):118-21. PubMed ID: 9067751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
    Zegers BJ; Stoop JW
    Clin Biochem; 1983 Feb; 16(1):43-7. PubMed ID: 6407780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case Report: Hodgkin Lymphoma and Refractory Systemic Lupus Erythematosus Unveil Activated Phosphoinositide 3-Kinase-δ Syndrome 2 in an Adult Patient.
    Conti F; Catelli A; Cifaldi C; Leonardi L; Mulè R; Fusconi M; Stefoni V; Chiriaco M; Rivalta B; Di Cesare S; Schifino G; Sbrega F; Di Matteo G; Ferrari S; Cancrini C; Pession A
    Front Pediatr; 2021; 9():702546. PubMed ID: 34307262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.